Accumulated sotorasib-bound KRASG12C reactivates the MAPK pathway and drives sotorasib resistance via the DHX9-RAC1-PAK1 axis
Key Points
This research aims to understand how accumulated sotorasib-bound KRASG12C leads to drug resistance.
Developed sotorasib-resistant models to study resistance mechanisms.
Examined the role of the DHX9-RAC1-PAK1 axis in reactivating the MAPK pathway.
Utilized molecular analysis techniques to assess pathway activation.
Accumulated sotorasib-bound KRASG12C drives reactivation of the MAPK pathway.
The DHX9-RAC1-PAK1 axis is identified as a key mechanism of sotorasib resistance.
Insights from this study may inform future therapeutic strategies.
Abstract
-mutant and sotorasib-resistant models. These findings provide previously uncharacterized mechanistic insights to guide therapeutic strategies aimed at overcoming sotorasib resistance.
AI에게 질문
Like
Bookmark
Share
View Full Paper
AI에게 질문
Like
Bookmark
Share
View Full Paper
Accumulated sotorasib-bound KRASG12C reactivates the MAPK pathway and drives sotorasib resistance via the DHX9-RAC1-PAK1 axis | Synapse